Johnson & Johnson (JNJ) - Halal (Shariah-Compliant)
Johnson & Johnson (JNJ) is classified as Halal (Shariah-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Result
- Pass
- Reason
- The sector "Healthcare" and industry "Drug Manufacturers - General" are not in the excluded categories.
Financial Ratios
- Debt Ratio
- Value: 9.8% | Threshold: 30% | Result: Pass
- Cash & Interest-bearing Securities Ratio
- Value: 4.2% | Threshold: 30% | Result: Pass
- Non-Permissible Income Ratio
- Value: 1.0% | Threshold: 5% | Result: Pass
Dividend Purification
Purification percentage: 1.04%.Based on the company's financial statements, approximately 1.04% of dividend income should be donated to charity for purification. This is derived from identified interest income (1.04% of total income). Some scholars may differ on the exact calculation method.
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
